Digital AI in Drug Discovery: Day One There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.
Digital The next chapter for AI protein structure prediction When Alphabet announced in 2021 that its AlphaFold AI could predict the structure of almost
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.